Recreating Complex Pathophysiologies In Vitro with Extracellular Matrix Surrogates for Anticancer Therapeutics Screening In Vitro Cancer Models with ECM Surrogates

Dimitrios Zeugolis

Research output: Contribution to a Journal (Peer & Non Peer)Articlepeer-review

Abstract

In vitro tumour models utilise various cancer cells and an appropriate extracellular matrix equivalent to recapitulate the in vivo tumour microenvironment. Three-dimensional tissue surrogates (e.g., decellularised tissue grafts, decellularised monolayers, hydrogels, electrospun fibres and sponges) are increasingly used as alternatives to conventional two-dimensional monolayer cultures to model the tissue environment more faithfully for drug development and screening. Herein, we critically assess the advances and shortfalls of these three-dimensional systems as in vitro models of cancer.
Original languageEnglish (Ireland)
JournalDrug Discovery Today
Volume21
Issue number9
Publication statusPublished - 1 Sep 2016

Authors (Note for portal: view the doc link for the full list of authors)

  • Authors
  • Shologu, N., Szegezdi, E., Lowery, A., Kerin, M., Pandit, A. and Zeugolis, D.I.

Fingerprint

Dive into the research topics of 'Recreating Complex Pathophysiologies In Vitro with Extracellular Matrix Surrogates for Anticancer Therapeutics Screening In Vitro Cancer Models with ECM Surrogates'. Together they form a unique fingerprint.

Cite this